These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 25917767)
1. Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates. Ohls RK; Christensen RD; Widness JA; Juul SE J Pediatr; 2015 Jul; 167(1):10-2. PubMed ID: 25917767 [No Abstract] [Full Text] [Related]
2. Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants. Fauchère JC; Koller BM; Tschopp A; Dame C; Ruegger C; Bucher HU; J Pediatr; 2015 Jul; 167(1):52-7.e1-3. PubMed ID: 25863661 [TBL] [Abstract][Full Text] [Related]
3. Systematic review seeking erythropoietin role for neuroprotection in neonates with hypoxic ischemic encephalopathy: presently where do we stand. Garg B; Sharma D; Bansal A J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3214-3224. PubMed ID: 28797191 [TBL] [Abstract][Full Text] [Related]
4. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial. Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC; JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300 [TBL] [Abstract][Full Text] [Related]
5. Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report. Luciano R; Fracchiolla A; Ricci D; Cota F; D'Andrea V; Gallini F; Papacci P; Mercuri E; Romagnoli C Ital J Pediatr; 2015 Sep; 41():64. PubMed ID: 26376632 [TBL] [Abstract][Full Text] [Related]
6. Awaiting evidence of neuroprotective effects of recombinant erythropoietin in very preterm infants. Dame C J Perinatol; 2013 May; 33(5):411. PubMed ID: 23624973 [No Abstract] [Full Text] [Related]
7. Neuroprotection with erythropoietin in preterm and/or low birth weight infants. Zhang J; Wang Q; Xiang H; Xin Y; Chang M; Lu H J Clin Neurosci; 2014 Aug; 21(8):1283-7. PubMed ID: 24650681 [TBL] [Abstract][Full Text] [Related]
8. Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants. Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Fauchère JC; JAMA; 2020 Dec; 324(22):2324-2327. PubMed ID: 33289818 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective role of erythropoietin in neonates. Juul S J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():105-7. PubMed ID: 22958035 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of erythropoiesis-stimulating agents in term and preterm neonates. Messier AM; Ohls RK Curr Opin Pediatr; 2014 Apr; 26(2):139-45. PubMed ID: 24535496 [TBL] [Abstract][Full Text] [Related]